SD

Sheela Devi

Active Director Director DIN 05145889
DIN 05145889 First appointment Oct 2000 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2000
Shareholding value •••• Premium profile

About Sheela Devi

Data last updated:

Sheela Devi is a Director at Omenta Pharma Private Limited (since 2000). The company operates in Trading. Omenta Pharma Private Limited reported revenue of ₹1.98 Cr (FY 2025).

DIN 05145889
Primary Designation Director
Industry Trading
First Appointment 22 Oct 2000
Oldest Company Age 26 yrs
Largest company Omenta Pharma Private Limited · ₹1.98 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Omenta Pharma Private Limited U51397DL2000PTC108265
Director22 Oct 20002000₹1.98 Cr (FY 2025)Active

Board colleagues of Sheela Devi

NameDINCompanyDesignation
Sparsh Garg09638969Omenta Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Omenta Pharma Private Limited
Premium access

Shareholding and investment profile for Sheela Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sheela Devi

Sheela Devi currently holds 1 directorship: Omenta Pharma Private Limited (Director, since 22 Oct 2000, revenue ₹1.98 Cr (FY 2025)).

Sheela Devi was first appointed on 22 Oct 2000 as Director at Omenta Pharma Private Limited.

The current boards of Sheela Devi's companies include Sparsh Garg (Omenta Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available